PCN Insights, News, Videos, and More

Specific metabolites may predict which patients with major depressive disorder are at risk for recurrence, a study published online in Translational Psychiatry suggests.

Three major molecular subtypes of Alzheimer disease identified by researchers could be biomarkers that lead to earlier diagnosis and intervention.

Long-acting injectable (LAI) paliperidone palmitate significantly improved outcomes in patients with schizophrenia despite duration of illness, but those with shorter illness duration showed the best improvement, a study found.

Research studies that will investigate perinatal depression in women and possible new treatments for it will be led by Kristina Deligiannidis, MD, of the Feinstein Institutes' Institute of Behavioral Science, Glen Oaks, New York.

The protein transthyretin (TTR) may play a role in the development of new treatments for Alzheimer’s disease by preventing the formation of amyloid beta clumps, according to a study.

Psychedelic medicine biotech firm MindMed has announced the launch of a clinical trial that will evaluate the use of MDMA and LSD in combination. The trial will look to determine whether MDMA can increase positive subject drug effects and...